Literature DB >> 18424476

Clinical features of patients with multiple sclerosis from a survey in Shanghai, China.

Q Cheng1, L Miao, J Zhang, Y T Guan, Z G Liu, X Wang, X J Sun, Z X Zhao, Y J Song, X Y Ding, Z I Guo, X J Cheng, S D Chen, G X Jiang, S Fredrikson.   

Abstract

OBJECTIVE: To describe clinical features of patients with multiple sclerosis (MS) in Shanghai, China.
METHODS: Prevalent patients with MS were identified and investigated by a network of physicians in 11 districts of Shanghai during the period from 1 September 2004 to 31 August 2005. Admission registries of each hospital in the study area were checked systematically for patients with a diagnosis of MS, neuromyelitis optica or other demyelinating disorders. All patients with collected information were evaluated by four senior neurologists according to the McDonald criteria.
RESULTS: There were 249 (146 female and 103 male) patients with a confirmed MS diagnosis, at a female-to-male ratio of 1.4. The mean age at onset of MS was 37.4 years for the 249 patients with MS and, on the prevalence day, 42.7 years. The most frequent location of clinical MS lesions in the central nervous system was the spinal cord (61%), followed by the cerebrum (55%) and optic nerves (41%). Nearly all (96%) of the patients with MS had been examined by magnetic resonance imaging, and 226 (94%) patients of those examined were suggestive of MS. No family history of MS was found in any of the patients. Most (86%) of the patients had no or mild disability on the prevalence day (31 December 2004). Almost all (96%) patients with MS had been treated with corticosteroids.
CONCLUSION: Clinical features of patients with MS are described based on the information from the largest case series reported among Chinese. Comparisons and discussions are made with findings from the other populations.

Entities:  

Mesh:

Year:  2008        PMID: 18424476     DOI: 10.1177/1352458507087844

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

Review 1.  Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics.

Authors:  DeRen Huang
Journal:  Neurosci Bull       Date:  2015-12       Impact factor: 5.203

2.  Neurology and neurologic practice in China.

Authors:  Fu-Dong Shi; Jian-Ping Jia
Journal:  Neurology       Date:  2011-11-29       Impact factor: 9.910

Review 3.  A Comparison of Optic Neuritis in Asian and in Western Countries.

Authors:  Lin-Chung Woung; Hui-Chuan Chung; Jieh-Ren Jou; Kai-Chen Wang; Pai-Huei Peng
Journal:  Neuroophthalmology       Date:  2011-03-20

Review 4.  Review of the diagnosis and clinical features of multiple sclerosis in China.

Authors:  Xiao-Juan Cheng; Li-Zhen Xu
Journal:  Neurosci Bull       Date:  2009-02       Impact factor: 5.203

5.  Activities of daily living and lesion position among multiple sclerosis patients by Bayes network.

Authors:  Zhifang Pan; Hongtao Lu; Qi Cheng
Journal:  Neural Regen Res       Date:  2013-05-15       Impact factor: 5.135

6.  Multiple Sclerosis in the Asia Pacific Region: A Systematic Review of a Neglected Neurological Disease.

Authors:  Wing L Cheong; Devi Mohan; Narelle Warren; Daniel D Reidpath
Journal:  Front Neurol       Date:  2018-06-08       Impact factor: 4.003

7.  IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis.

Authors:  Yang Zheng; Meng-Ting Cai; Fan Yang; Ji-Ping Zhou; Wei Fang; Chun-Hong Shen; Yin-Xi Zhang; Mei-Ping Ding
Journal:  Front Immunol       Date:  2020-08-20       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.